ClinConnect ClinConnect Logo
Search / Trial NCT05673499

International Study of Cerebral Oxygenation and Electrical Activity During Major Neonatal Surgery

Launched by CHILDREN'S HOSPITAL OF PHILADELPHIA · Dec 21, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Electroencephalography Near Infrared Spectroscopy

ClinConnect Summary

This clinical trial is studying brain oxygen levels and electrical activity in newborns who are undergoing major surgery for birth defects. The researchers want to find out how often babies experience a drop in brain oxygen levels during surgery and what factors might contribute to this. They will also look at how these changes in brain oxygen relate to the babies' overall health and recovery after surgery.

To participate in this study, infants must be 60 weeks or younger in terms of their development and scheduled for surgery related to specific congenital conditions, such as issues with the intestines or lungs. Parents or guardians will need to give permission for their child to join. During the trial, babies will be monitored using special equipment to measure brain activity and oxygen levels for about an hour before surgery, throughout the surgery, and for up to 24 hours afterward. This research aims to improve understanding and care for newborns undergoing these important procedures.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Infants ≤ 60 weeks post-menstrual age on day of surgery.
  • 2. Neonatal surgery for congenital abdominal/gastrointestinal malformations (diaphragmatic hernia, gastroschisis, omphalocele, intestinal atresia, Hirschsprung's disease, imperforate anus, necrotizing enterocolitis), congenital cystic adenomatoid/pulmonary airway malformation (CCAM/CPAM), esophageal/tracheoesophageal fistula (EF/TEF), and spinal malformations (myelomeningocele, sacrococcygeal teratoma).
  • 3. The same patient may be enrolled multiple times for repeat or different procedures that meet the above criteria. These subjects will be counted more than once towards the enrollment goal.
  • 4. Parental/guardian permission.
  • Exclusion Criteria:
  • 1) Patients with hydrocephalus limiting frontal-parietal brain volume, interventricular hemorrhage (grades 3 or 4), malformation or cerebral infarction of frontal-parietal brain.

About Children's Hospital Of Philadelphia

The Children's Hospital of Philadelphia (CHOP) is a leading pediatric healthcare institution renowned for its commitment to advancing child health through innovative research and clinical care. As a prominent clinical trial sponsor, CHOP emphasizes a multidisciplinary approach to pediatric research, fostering collaborations across various specialties to develop and evaluate groundbreaking therapies and interventions. With a focus on improving patient outcomes and enhancing the quality of life for children, CHOP is dedicated to conducting rigorous clinical trials that adhere to the highest ethical standards and scientific integrity, ultimately contributing to the global knowledge base in pediatric medicine.

Locations

Philadelphia, Pennsylvania, United States

Dallas, Texas, United States

Houston, Texas, United States

Vellore, , India

New York, New York, United States

Chandigarh, , India

London, , United Kingdom

Parkville, , Australia

Shenyang, , China

Shanghai, , China

Guangzhou, , China

Nedlands, , Australia

São Paulo, , Brazil

Sichuan, , China

Bordeaux, , France

New York, New York, United States

Patients applied

0 patients applied

Trial Officials

Ian Yuan, MD

Principal Investigator

Children's Hospital of Philadelphia

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials